The following data is part of a premarket notification filed by Bayer Corp. with the FDA for Clinitek Atlas Pro 12 Reagent Pak System.
Device ID | K021428 |
510k Number | K021428 |
Device Name: | CLINITEK ATLAS PRO 12 REAGENT PAK SYSTEM |
Classification | Enzymatic Method, Creatinine |
Applicant | BAYER CORP. 511 BENEDICT AVE. Tarrytown, NY 10591 -5097 |
Contact | Kenneth T Edds |
Correspondent | Kenneth T Edds BAYER CORP. 511 BENEDICT AVE. Tarrytown, NY 10591 -5097 |
Product Code | JFY |
Subsequent Product Code | CDM |
Subsequent Product Code | CEN |
Subsequent Product Code | JIL |
Subsequent Product Code | JIN |
Subsequent Product Code | JIP |
Subsequent Product Code | JIR |
Subsequent Product Code | JJB |
Subsequent Product Code | JMT |
Subsequent Product Code | JRE |
Subsequent Product Code | KQO |
Subsequent Product Code | LJX |
CFR Regulation Number | 862.1225 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2002-05-03 |
Decision Date | 2002-07-05 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
00630414479095 | K021428 | 000 |